July 2013

Agharkar Research Institute (ARI) is an autonomous, grant-in-aid research institute of the Department of Science and Technology (DST), Goverment of India. It was established in 1946 by the Maharashtra Association for the Cultivation of Science as MACS Research Institute and renamed as ARI in 1992 in honour and memory of its founder Director, late Professor S.P. Agharkar.

Walk-in-interview will be held to engage Para Medical Staff on contract basis for the period upto 30-06-2014 from the date of engagement as per details given below:-

Post: Pharmacist

Pharma MNC

Post: Head R&D

With a coastline of about 3,500 miles, inland sources in Rajasthan and Little Rann of Kutch, and the rock salt mines in Mandi, India have possibilities of attaining a high position in salt production among the salt producing countries of the world. As is known, apart from being an indispensable item of food, salt is an important raw material for the manufacture of several heavy chemicals e.g. soda ash, caustic soda and chlorine.

About Author:
Mridula Jayaraman,
Amity Institute of Pharmacy,
Amity University, India
mridulajayaraman1990@gmail.com

Abstract
The word ‘cancer’ itself sends chills down our spines as its prognosis and treatment, even if detected at an early stage is cumbersome and tortuous. With the advent of modern medicines, even though it is claimed that cancer is curable, there exists virtually no chemotherapeutic agent for cancer without side effect(s), not to mention the cost of these medicines which are skyrocketing.
Hence, we are left with little choice but to go for new fronts in research on the therapeutic agents present in plants (Phytotherapy), which are not only cost effective but also relatively side effects free.  These plants are available in plenty in the Himalayan and Aravali Region of India.  
University of Wisconsin lists 150 plants which they have established as having potential value in the treatment of cancer.  However, the real issue here is that not many drugs derived from plants have been standardized and standardization of these plants for therapeutic purpose is still in the nascent stage.

About Author:
Shambhavi Singh
M.pharma, Singhania University
Jhunjhunu, Rajasthan
Shambhavisingh6777@gmail.com

Abstract
Based on the figures from the World Health Organization, more than 20 lakhs women die worldwide because of cervical cancer per year. Cervical cancer, a potentially preventable disease, found as the second most common malignancy in women worldwide. In India, the disease accounts for a probable 24 percent of  India’s cancer cases among women and in addition to that 74,000 Indian women die annually from the disease, which results from the unusual growth of cells in the cervix. Cervical cancer is the most frequent disorder among women age near about 50 that increased the death rate  in  Indian rural women as compared urban due to lack awareness and don’t gain proper education. Cancer causing growth in the cervix is not a solitary type. It is not usually linked with hereditary genetic factor but a number of variable factors (Chemical, environmental and biological) indirectly enhance the risk of cervical cancer by increasing the possibility that a woman can contact an HPV infection. National Cancer Control Program emphasizes the significance of early detection and treatment. But our country has no well thought-out screening program and many women in India lack information regarding the disease and way to prevention and treatment facilities. Therefore, it is most of important to treat properly cervical cancer and make awareness in Indian women regarding its treatment and proper management.

The Jaypee Group of Companies has consistently displayed full awareness of its social responsibilities through the Jaiprakash Sewa Sansthan (JSS), a ‘not for profit’ Trust.

The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC, Kharghar, Navi Mumbai is the new state-of-the-art R&D satellite of the Tata Memorial Centre (TMC), which also includes under its umbrella the Tata Memorial Hospital (TMH), the largest cancer hospital in Asia. ACTREC has the mandate to function as a national centre for treatment, research and education in cancer. TMC is an autonomous grant-in-aid institution of the Department of Atomic Energy (DAE), Government of India.